Wang ZY - Search Results

1

G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases.

Li N, Shan S, Li XQ, Chen TT, Qi M, Zhang SN, Wang ZY, Zhang LL, Wei W, Sun WY. Li N, et al. Among authors: wang zy. Front Immunol. 2022 Jan 17;12:822345. doi: 10.3389/fimmu.2021.822345. eCollection 2021. Front Immunol. 2022. PMID: 35111168 Free PMC article. Review.

2

Inflammasome as an Effective Platform for Fibrosis Therapy.

Chen TT, Xiao F, Li N, Shan S, Qi M, Wang ZY, Zhang SN, Wei W, Sun WY. Chen TT, et al. Among authors: wang zy. J Inflamm Res. 2021 Apr 20;14:1575-1590. doi: 10.2147/JIR.S304180. eCollection 2021. J Inflamm Res. 2021. PMID: 33907438 Free PMC article. Review.

3

Gpr97 Exacerbates AKI by Mediating Sema3A Signaling.

Fang W, Wang Z, Li Q, Wang X, Zhang Y, Sun Y, Tang W, Ma C, Sun J, Li N, Yi F. Fang W, et al. J Am Soc Nephrol. 2018 May;29(5):1475-1489. doi: 10.1681/ASN.2017080932. Epub 2018 Mar 12. J Am Soc Nephrol. 2018. PMID: 29531097 Free PMC article.

4

GPR87 promotes renal tubulointerstitial fibrosis by accelerating glycolysis and mitochondrial injury.

Cui X, Shi E, Li J, Li Y, Qiao Z, Wang Z, Liu M, Tang W, Sun Y, Zhang Y, Xie Y, Zhen J, Wang X, Yi F. Cui X, et al. Free Radic Biol Med. 2022 Aug 20;189:58-70. doi: 10.1016/j.freeradbiomed.2022.07.004. Epub 2022 Jul 14. Free Radic Biol Med. 2022. PMID: 35843477

5

NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice.

Li X, Li F, Chu Y, Wang X, Zhang H, Hu Y, Zhang Y, Wang Z, Wei X, Jian W, Zhang X, Yi F. Li X, et al. Cell Physiol Biochem. 2013;32(6):1857-66. doi: 10.1159/000356618. Epub 2013 Dec 20. Cell Physiol Biochem. 2013. PMID: 24356239 Free article.

6

β-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1/β-catenin signaling in mice.

Xu H, Li Q, Liu J, Zhu J, Li L, Wang Z, Zhang Y, Sun Y, Sun J, Wang R, Yi F. Xu H, et al. J Mol Med (Berl). 2018 Jan;96(1):97-109. doi: 10.1007/s00109-017-1606-5. Epub 2017 Nov 7. J Mol Med (Berl). 2018. PMID: 29116339

7

JAML promotes acute kidney injury mainly through a macrophage-dependent mechanism.

Huang W, Wang BO, Hou YF, Fu Y, Cui SJ, Zhu JH, Zhan XY, Li RK, Tang W, Wu JC, Wang ZY, Wang M, Wang XJ, Zhang Y, Liu M, Xie YS, Sun Y, Yi F. Huang W, et al. Among authors: wang bo, wang zy, wang xj, wang m. JCI Insight. 2022 Jun 16;7(14):e158571. doi: 10.1172/jci.insight.158571. JCI Insight. 2022. PMID: 35708906 Free PMC article.

8

Therapeutic Potential of Novel Twin Compounds Containing Tetramethylpyrazine and Carnitine Substructures in Experimental Ischemic Stroke.

Wang Z, Zhou Z, Wei X, Wang M, Wang BO, Zhang Y, He X, Sun Y, Wang X, Sun M, Zhang Y, Gong X, Yi F. Wang Z, et al. Oxid Med Cell Longev. 2017;2017:7191856. doi: 10.1155/2017/7191856. Epub 2017 Dec 13. Oxid Med Cell Longev. 2017. PMID: 29387294 Free PMC article.

9

Targeting tissue-resident memory CD8⁺ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis.

Li L, Tang W, Zhang Y, Jia M, Wang L, Li Q, Han Q, Peng X, Xie Y, Wu J, Wang Z, Zhen J, Wang X, Liu M, Sun Y, Zhang C, Yi F. Li L, et al. Mol Ther. 2022 Aug 3;30(8):2746-2759. doi: 10.1016/j.ymthe.2022.04.024. Epub 2022 May 5. Mol Ther. 2022. PMID: 35514086 Free PMC article.

10

GPR97 deficiency ameliorates renal interstitial fibrosis in mouse hypertensive nephropathy.

Wu JC, Wang XJ, Zhu JH, Huang XY, Liu M, Qiao Z, Zhang Y, Sun Y, Wang ZY, Zhan P, Zhang T, Hu HL, Liu H, Tang W, Yi F. Wu JC, et al. Among authors: wang zy, wang xj. Acta Pharmacol Sin. 2023 Jun;44(6):1206-1216. doi: 10.1038/s41401-022-01041-y. Epub 2023 Jan 12. Acta Pharmacol Sin. 2023. PMID: 36635422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,826 results

Search Page